Literature DB >> 27198716

Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma.

Piers Blombery1, Ella R Thompson2, Kate Jones3, Gisela Mir Arnau3, Stephen Lade2, John F Markham3, Jason Li3, Anand Deva4, Ricky W Johnstone3, Amit Khot3, H Miles Prince3, David Westerman2.   

Abstract

Entities:  

Keywords:  Breast implant-associated anaplastic large cell lymphoma; STAT3; exome

Mesh：

Substances：

Year:  2016        PMID： 27198716      PMCID： PMC5060038          DOI： 10.3324/haematol.2016.146118

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

1.  Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma.

Authors:  Qian Zhang; Puthryaveett N Raghunath; Liquan Xue; Miroslaw Majewski; David F Carpentieri; Niels Odum; Stephan Morris; Tomasz Skorski; Mariusz A Wasik
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

2.  Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases.

Authors:  Garry S Brody
Journal:  Plast Reconstr Surg       Date:  2015-10       Impact factor: 4.730

3.  In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants.

Authors:  Anita Jacombs; Shamaila Tahir; Honghua Hu; Anand K Deva; Ahmad Almatroudi; William Louis Fick Wessels; David A Bradshaw; Karen Vickery
Journal:  Plast Reconstr Surg       Date:  2014-04       Impact factor: 4.730

4.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

5.  Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma.

Authors:  Tracy J Lightfoot; Christine F Skibola; Alex G Smith; Matthew S Forrest; Peter J Adamson; Gareth J Morgan; Paige M Bracci; Eve Roman; Martyn T Smith; Elizabeth A Holly
Journal:  Haematologica       Date:  2006-09       Impact factor: 9.941

6.  Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.

Authors:  Alberto Zamo; Roberto Chiarle; Roberto Piva; Jennifer Howes; Yan Fan; Marco Chilosi; David E Levy; Giorgio Inghirami
Journal:  Oncogene       Date:  2002-02-07       Impact factor: 9.867

7.  ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Authors:  Kerry J Savage; Nancy Lee Harris; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Joseph M Connors; Lisa Rimsza; Stefano A Pileri; Mukesh Chhanabhai; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2008-04-02       Impact factor: 22.113

8.  JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.

Authors:  A Bouchekioua; L Scourzic; O de Wever; Y Zhang; P Cervera; A Aline-Fardin; T Mercher; P Gaulard; R Nyga; D Jeziorowska; L Douay; W Vainchenker; F Louache; C Gespach; E Solary; P Coppo
Journal:  Leukemia       Date:  2013-05-21       Impact factor: 11.528

Review 9.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

10.  Emergence of a STAT3 mutated NK clone in LGL leukemia.

Authors:  Yiyi Yan; Thomas L Olson; Susan B Nyland; David J Feith; Thomas P Loughran
Journal:  Leuk Res Rep       Date:  2014-12-16
View more
  32 in total

Review 1.  Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Akira Satou; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2019-07-31       Impact factor: 2.929

2.  T-cell and NK-cell neoplasms of the gastrointestinal tract - recurrent themes, but clinical and biological distinctions exist.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2020-07       Impact factor: 9.941

3.  Capsular Contracture in Breast Implant Surgery: Where Are We Now and Where Are We Going?

Authors:  Yara Bachour
Journal:  Aesthetic Plast Surg       Date:  2021-02-08       Impact factor: 2.326

4.  Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Authors:  Naoki Oishi; Garry S Brody; Rhett P Ketterling; David S Viswanatha; Rong He; Surendra Dasari; Ming Mai; Hailey K Benson; Christopher A Sattler; Rebecca L Boddicker; Ellen D McPhail; N Nora Bennani; Christin A Harless; Kuldeep Singh; Mark W Clemens; L Jeffrey Medeiros; Roberto N Miranda; Andrew L Feldman
Journal:  Blood       Date:  2018-06-19       Impact factor: 22.113

5.  The Cellular Origins of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Implications for Immunogenesis.

Authors:  Suzanne Dawn Turner
Journal:  Aesthet Surg J       Date:  2019-01-31       Impact factor: 4.283

6.  Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.

Authors:  Camille Laurent; Alina Nicolae; Cécile Laurent; Fabien Le Bras; Corinne Haioun; Virginie Fataccioli; Nadia Amara; José Adélaïde; Arnaud Guille; Jean-Marc Schiano; Bruno Tesson; Alexandra Traverse-Glehen; Marie-Pierre Chenard; Lénaïg Mescam; Anne Moreau; Catherine Chassagne-Clement; Joan Somja; Frédéric Escudié; Marc André; Nadine Martin; Laetitia Lacroix; François Lemonnier; Anne-Sophie Hamy; Fabien Reyal; Marie Bannier; Lucie Oberic; Nais Prade; François-Xavier Frénois; Asma Beldi-Ferchiou; Marie-Helene Delfau-Larue; Reda Bouabdallah; Daniel Birnbaum; Pierre Brousset; Luc Xerri; Philippe Gaulard
Journal:  Blood       Date:  2020-01-30       Impact factor: 22.113

7.  Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.

Authors:  Audrey Letourneau; Marie Maerevoet; Dina Milowich; Roland Dewind; Bettina Bisig; Edoardo Missiaglia; Laurence de Leval
Journal:  Virchows Arch       Date:  2018-04-10       Impact factor: 4.064

Review 8.  Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  Mark W Clemens; Ryan C DeCoster; Berry Fairchild; Alexander A Bessonov; Fabio Santanelli di Pompeo
Journal:  Semin Plast Surg       Date:  2019-10-17       Impact factor: 2.314

Review 9.  Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Authors:  P Rastogi; A K Deva; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

10.  Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Authors:  Elaine S Jaffe; Binita S Ashar; Mark W Clemens; Andrew L Feldman; Philippe Gaulard; Roberto N Miranda; Aliyah R Sohani; Timothy Stenzel; Sung W Yoon
Journal:  J Clin Oncol       Date:  2020-02-11       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.